Lv3
400 积分 2023-12-04 加入
Engineering CHO cells with an oncogenic KIT improves cells growth, resilience to stress, and productivity
9天前
已完结
Co-expression enhances cloning efficiency and protein production in CHO cells
9天前
已完结
Modulation of therapeutic antibody effector functions by glycosylation engineering: Influence of Golgi enzyme localization domain and co‐expression of heterologous β1, 4‐N‐acetylglucosaminyltransferase III and Golgi α‐mannosidase II
3个月前
已完结
Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity
3个月前
已完结
Antibody Glycosylation and Its Impact on the Pharmacokinetics and Pharmacodynamics of Monoclonal Antibodies and Fc-Fusion Proteins
3个月前
已完结
Cell line development and bioreactor process optimization for an atezolizumab biosimilar
3个月前
已完结
Recent advances in the understanding of biological implications and modulation methodologies of monoclonal antibody N‐linked high mannose glycans
3个月前
已完结
Carboxypeptidase D is the only enzyme responsible for antibody C‐terminal lysine cleavage in Chinese hamster ovary (CHO) cells
3个月前
已完结
CRISPR‐interceded CHO cell line development approaches
3个月前
已完结
CRISPR/Cas9‐mediated genome engineering of CHO cell factories: Application and perspectives
3个月前
已完结
皖公网安备34019202002308
